The goal of this program is to provide high quality research training in the biomedical investigation of the rheumatic diseases, focused on basic immunological mechanisms. The program has developed a research training environment conducive to the proper nurturing of young scientists interested in the rheumatic diseases as evidenced by the large number of researchers and academics who have trained here. For the first 25 years of this training grant, only post-doctoral training was supported with the addition of training of Ph.D. scientists during the last grant cycle. In this grant, we renew this commitment. The training will occur under the direction of training faculty in six major areas relevant to the immunobiology of rheumatic diseases, including 1) Animal models of rheumatic disease; 2) Autoimmunity and tolerance; 3) Inflammation; 4) Antigen processing and MHC molecules; 5) Immunoregulation and host defense; 6) Receptor signaling and lymphocyte development; and 7) Genetics of immune responses, receptors, and rheumatic disease therapy. Training faculty include members of the Rheumatology Division and Medical Oncology in the Department of Medicine, the Division of Allergy, Immunology, and Rheumatology in the Department of Pediatrics, Departments of Pathology and Immunology, Molecular Biology and Pharmacology, and Genetics. Both physician-scientists (M.D. and M.D., Ph.D.) and basic scientists (Ph.D.) preceptors form the Program faculty who are dedicated to training the next generation of basic scientists interested in the immunobiology of the rheumatic diseases. In addition, trainees will be required to attend seminars and conferences that are devoted to clinical aspects of Rheumatology and the translation of basic research to the clinic. This aspect of training provides exposure to clinical issues and opportunities for new research. Thus, this program will continue to produce high quality researchers interested in the immunobiology of the rheumatic diseases.
| Kulkarni, Hrishikesh S; Witt, Chad A (2018) Voriconazole in lung transplant recipients - how worried should we be? Am J Transplant 18:5-6 |
| Kulkarni, Hrishikesh S; Elvington, Michelle L; Perng, Yi-Chieh et al. (2018) Intracellular C3 Protects Human Airway Epithelial Cells from Stress-Associated Cell Death. Am J Respir Cell Mol Biol : |
| Kulkarni, Hrishikesh S; Liszewski, M Kathryn; Brody, Steven L et al. (2018) The complement system in the airway epithelium: An overlooked host defense mechanism and therapeutic target? J Allergy Clin Immunol 141:1582-1586.e1 |
| Liszewski, M Kathryn; Elvington, Michelle; Kulkarni, Hrishikesh S et al. (2017) Complement's hidden arsenal: New insights and novel functions inside the cell. Mol Immunol 84:2-9 |
| Elvington, Michelle; Liszewski, M Kathryn; Bertram, Paula et al. (2017) A C3(H20) recycling pathway is a component of the intracellular complement system. J Clin Invest 127:970-981 |
| Hoegl, Sandra; Ehrentraut, Heidi; Brodsky, Kelley S et al. (2017) NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury. J Leukoc Biol 101:471-480 |
| Schmid, Edward T; Pang, Iris K; Carrera Silva, Eugenio A et al. (2016) AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity. Elife 5: |
| Elvington, Michelle; Liszewski, M Kathryn; Atkinson, John P (2016) Evolution of the complement system: from defense of the single cell to guardian of the intravascular space. Immunol Rev 274:9-15 |
| Speer, Scott D; Li, Zhi; Buta, Sofija et al. (2016) ISG15 deficiency and increased viral resistance in humans but not mice. Nat Commun 7:11496 |
| Miner, Jonathan J; Diamond, Michael S (2016) Mechanisms of restriction of viral neuroinvasion at the blood-brain barrier. Curr Opin Immunol 38:18-23 |
Showing the most recent 10 out of 62 publications
